• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. DENALI FEMORAL SYSTEM; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. DENALI FEMORAL SYSTEM; VENA CAVA FILTER Back to Search Results
Catalog Number DL900F
Device Problems Difficult to Remove (1528); Malposition of Device (2616); Patient-Device Incompatibility (2682); Detachment of Device or Device Component (2907); Material Deformation (2976)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/30/2020
Event Type  malfunction  
Manufacturer Narrative
As the lot number for the device was not provided, a review of the device history records could not be performed.The device has not been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient after being diagnosed with pulmonary thromboembolism.Six months and ten days post filter deployment, it was alleged that the filter had detached, material deformed, perforated, and the filter tilted.The device has not been removed after an attempted but unsuccessful percutaneous removal procedure.There was no reported patient injury.
 
Manufacturer Narrative
H10: manufacturing review: a manufacturing review was not requested as the lot number reported as unknown.Investigation summary: the device was not returned for evaluation.The medical records included images.The image review was documented in the medical records.The denali ivc filter is deployed in what is presumed to be the inferior vena cava.The tip of the filter is at the l1-l2 disc level.It is upright with no significant tilt.The struts all appear to be deployed.Medical records were provided and reviewed.Approximately six months and ten days post filter implantation, retrieval of the filter was performed.The right internal jugular vein was accessed using real-time ultrasound guidance.A 21-gauge micro-introducer needle was used to access the vein.A 0.018-inch cope wire was advanced into the superior vena cava.The needle was then exchanged for a 4-french micro-introducer sheath.The inner dilator and wire were removed and a 0.035-inch amplatz wire was placed into the inferior vena cava.The micro-introducer sheath was then removed.A 11-french coaxial bard retrieval kit was then advanced into the right iliac vein.An inferior venacavogram was performed demonstrating a patent inferior vena cava with bilateral renal inflow artifacts.There was flow void identified at the tip of the filter.The indwelling filter was attempted to be snared with the snare within the kit, followed by a amplatz goose-neck snare but the snare was not successful.Several attempts with various endobronchial forceps were attempted with minimal success.Oblique venograms were then performed demonstrating that the hook of the filter was within the right renal vein.The forceps were able to grasp the apex of the filter but were unsuccessful in efforts to try and gravity hook.Using a snare and a sos catheter, a micro-wire was used to surround the filter and was attempted to be retracted into the sheath however this failed.The decision was made then to abort the procedure as procedural time was elevated and likely a femoral approach may be required.A final venogram demonstrated filter positioning within the inferior/right renal vein, a few of the filter legs were flipped cranially.The wire and catheter were removed without difficulty.The right internal jugular sheath was removed, and hemostasis was attained.The patient tolerated the procedure well.There were no immediate complications.Around seventeen days later, repeat retrieval of the filter was performed.A scout radiograph revealed the filter tilted to the right and partially fractured.Under ultrasound guidance, a 21-gauge micro-introducer needle was used to access the right internal jugular vein.A 0.018-inch cope wire was advanced into the superior vena cava.The needle was then exchanged for a 4-french micro-introducer sheath.The inner dilator and wire were removed and a 0.035-inch amplatz wire was placed into the inferior vena cava.The micro-introducer sheath was then removed.A long 16-french vascular sheath was then placed over the wire.Venogram through the femoral sheath demonstrated no thrombus surrounding the filter.Using forceps, the three superiorly positioned prongs were repositioned inferiorly, one of which was removed after fracturing.Numerous attempts to retrieve the filter were unsuccessful using forceps, snare, and loop snare with a reverse curve catheter technique.Multiple venograms in multiple obliques and projections demonstrate the filter tip protruding posteriorly beyond the inferior vena cava wall within the retroperitoneum.No extravasation was noted.All wires, catheters, and sheaths were removed.Hemostasis was obtained with manual pressure.The patient tolerated the procedure well.There were no immediate complications.Therefore, the investigation is confirmed for the reported filter detachment, deformation, perforation of inferior vena cava, filter tilt and retrieval difficulties.A definitive root cause could not be determined based upon the available information.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient after being diagnosed with pulmonary thromboembolism.Six months and ten days post filter deployment, it was alleged that the filter had detached, material deformed, perforated, and the filter tilted.The device has not been removed after an attempted but unsuccessful percutaneous removal procedure.There was no reported patient injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DENALI FEMORAL SYSTEM
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury 12804
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key17689456
MDR Text Key322709676
Report Number2020394-2023-00652
Device Sequence Number1
Product Code DTK
UDI-Device Identifier00801741040801
UDI-Public(01)00801741040801
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K130366
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Consumer,Health Professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 11/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/06/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberDL900F
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Date Manufacturer Received11/02/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age51 YR
Patient SexMale
-
-